Abstract
No public abstract is available from the verified source records.
Tanu Dixit, Sohini Chattopadhyay, Tan Thakur, Mansi Sawardekar, Selvan Ravindran
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Insights into exosome transport through the blood–brain barrier and the potential therapeutic applications in brain diseases
10.3390/ph16040571 · 2023
Response to fitzgerald et al. re: “Thyroid stimulating hormone and thyroid hormones (Triiodothyronine and Thyroxine): An American thyroid association-commissioned review of current clinical and laboratory status”
10.1089/thy.2024.0049 · 2024
Thyroid hormones and the brain
10.1006/frne.2000.0208 · 2001
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · 2008
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
10.1016/j.nano.2015.09.004 · 2016
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · 2007
Nanoparticle crossing of blood–blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases
10.2217/nnm-2018-0139 · 2018
Thyroid gland and brain: Enigma of hashimoto's encephalopathy
10.1016/j.beem.2019.101364 · 2019
Advances in nanocarrier-mediated delivery of chrysin: Enhancing solubility, bioavailability, and anticancer efficacy
2024
Current strategies for brain drug delivery
10.7150/thno.21254 · 2018
The thyroid axis and mood disorders: Overview and future prospects
1997
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
10.1074/jbc.m300909200 · 2003
Progress and perspectives on targeting nanoparticles for brain drug delivery
10.1016/j.apsb.2016.05.013 · 2016
Global transcriptome analysis of primary cerebrocortical cells: Identification of genes regulated by triiodothyronine in specific cell types
2017
Precision nanomedicine in neurodegenerative diseases
10.1021/nn501292z · 2014
Comparative approaches to understanding thyroid hormone regulation of neurogenesis
10.1016/j.mce.2017.05.020 · 2017
Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances
10.2174/1871524914666141030145948 · 2014
Pathophysiological importance of thyroid hormone transporters
10.1210/en.2008-1518 · 2009
Development of triiodothyronine polymeric nanoparticles for targeted delivery in the cardioprotection against ischemic insult
10.3390/biomedicines9111713 · 2021
Thyrotropin-releasing hormone-loaded and chitosan-engineered polymeric nanoparticles: Towards effective delivery of neuropeptides
10.1166/jnn.2016.12431 · 2016
Personalized nanomedicine for CNS diseases
10.1016/j.drudis.2017.11.010 · 2018
Nanoparticulate systems for brain delivery of drugs
10.1016/s0169-409x(00)00122-8 · 2001
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
10.1016/j.addr.2013.08.008 · 2014
Neurodegenerative disorders management: State-of-the-art and prospects of nano-biotechnology
10.1080/07388551.2021.1993126 · 2022
Personalized nanomedicine
10.1158/1078-0432.ccr-12-1414 · 2012
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability
2025
Nanoparticles for brain drug delivery
2013
Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis
10.1172/jci70324 · 2014
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
10.1007/s13346-012-0117-8 · 2013
How precise are nanomedicines in overcoming the blood–brain barrier? A comprehensive review of the literature
10.2147/ijn.s442520 · 2024
Review on thyroid disease
2023
Thyroid hormone action: Astrocyte–neuron communication
10.3389/fendo.2014.00082 · 2014
Thyroid hormone action 1994: The plot thickens
10.1530/eje.0.1300015 · 1994
Drug transport across the blood–brain barrier
10.1038/jcbfm.2012.126 · 2012
Enhancement of neuroprotective and anti-edema action in a mouse ischemic stroke model using T3 loaded nanoparticles
10.55940/medphar202463 · 2024
Genetic variation in thyroid hormone pathway genes: Polymorphisms in the TSH receptor and the iodothyronine deiodinases
10.1530/eje.1.02279 · 2006
Hypothyroidism and depression: A therapeutic challenge
10.1345/aph.10022 · 2000
Thyroid hormone signaling and adult neurogenesis in mammals
10.3389/fendo.2014.00062 · 2014
Factors and mechanisms of thyroid hormone activity in the brain: Possible role in recovery and protection
10.3390/biom14020198 · 2024
Nanotech approaches to drug delivery and imaging
10.1016/s1359-6446(03)02903-9 · 2003
Polymeric nanoparticles for the drug delivery to the central nervous system
10.1517/17425247.5.2.155 · doi-reference
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
10.1186/s12951-024-02681-4 · doi-reference
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
10.3389/fddev.2023.1247162 · doi-reference
Minireview: Thyroid hormone transporters: The knowns and the unknowns
10.1210/me.2010-0095 · doi-reference
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
10.2174/0929867311320170006 · doi-reference
Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges
10.1016/j.ccr.2023.215344 · doi-reference
Nanoparticle-based technology approaches to the management of neurological disorders
10.3390/ijms21176070 · doi-reference
A decrease in thyroid function after ischemic stroke is related to stroke severity
10.1186/s13044-023-00160-w · doi-reference
Nanoparticle-mediated brain drug delivery: Overcoming–brain barrier to treat neurodegenerative diseases
10.1016/j.jconrel.2016.05.044 · doi-reference
Nanotech approaches to drug delivery and imaging
10.1016/s1359-6446(03)02903-9 · doi-reference
Factors and mechanisms of thyroid hormone activity in the brain: Possible role in recovery and protection
10.3390/biom14020198 · doi-reference
Thyroid hormone signaling and adult neurogenesis in mammals
10.3389/fendo.2014.00062 · doi-reference
Hypothyroidism and depression: A therapeutic challenge
10.1345/aph.10022 · doi-reference
Genetic variation in thyroid hormone pathway genes: Polymorphisms in the TSH receptor and the iodothyronine deiodinases
10.1530/eje.1.02279 · doi-reference
Enhancement of neuroprotective and anti-edema action in a mouse ischemic stroke model using T3 loaded nanoparticles
10.55940/medphar202463 · doi-reference
Drug transport across the blood–brain barrier
10.1038/jcbfm.2012.126 · doi-reference
Thyroid hormone action 1994: The plot thickens
10.1530/eje.0.1300015 · doi-reference
Thyroid hormone action: Astrocyte–neuron communication
10.3389/fendo.2014.00082 · doi-reference
How precise are nanomedicines in overcoming the blood–brain barrier? A comprehensive review of the literature
10.2147/ijn.s442520 · doi-reference
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
10.1007/s13346-012-0117-8 · doi-reference
Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis
10.1172/jci70324 · doi-reference
Personalized nanomedicine
10.1158/1078-0432.ccr-12-1414 · doi-reference
Neurodegenerative disorders management: State-of-the-art and prospects of nano-biotechnology
10.1080/07388551.2021.1993126 · doi-reference
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
10.1016/j.addr.2013.08.008 · doi-reference
Nanoparticulate systems for brain delivery of drugs
10.1016/s0169-409x(00)00122-8 · doi-reference
Personalized nanomedicine for CNS diseases
10.1016/j.drudis.2017.11.010 · doi-reference
Thyrotropin-releasing hormone-loaded and chitosan-engineered polymeric nanoparticles: Towards effective delivery of neuropeptides
10.1166/jnn.2016.12431 · doi-reference
Development of triiodothyronine polymeric nanoparticles for targeted delivery in the cardioprotection against ischemic insult
10.3390/biomedicines9111713 · doi-reference
Pathophysiological importance of thyroid hormone transporters
10.1210/en.2008-1518 · doi-reference
Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances
10.2174/1871524914666141030145948 · doi-reference
Comparative approaches to understanding thyroid hormone regulation of neurogenesis
10.1016/j.mce.2017.05.020 · doi-reference
Precision nanomedicine in neurodegenerative diseases
10.1021/nn501292z · doi-reference
Progress and perspectives on targeting nanoparticles for brain drug delivery
10.1016/j.apsb.2016.05.013 · doi-reference
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
10.1074/jbc.m300909200 · doi-reference
Current strategies for brain drug delivery
10.7150/thno.21254 · doi-reference
Thyroid gland and brain: Enigma of hashimoto's encephalopathy
10.1016/j.beem.2019.101364 · doi-reference
Nanoparticle crossing of blood–blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases
10.2217/nnm-2018-0139 · doi-reference
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · doi-reference
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
10.1016/j.nano.2015.09.004 · doi-reference
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · doi-reference